Schnoll-Sussman Felice 4
4 · Interpace Diagnostics Group, Inc. · Filed Mar 9, 2018
Insider Transaction Report
Form 4
Schnoll-Sussman Felice
Director
Transactions
- Award
Common Stock
[F1][F2]2018-03-07+4,800→ 4,800 total - Award
Stock Option(right to buy)
[F3]2018-03-07+19,200→ 19,200 totalExercise: $1.01Exp: 2028-03-07→ Common Stock (19,200 underlying)
Footnotes (3)
- [F1]The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019.
- [F2]Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer").
- [F3]The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer.
Signature
/s/ Felice Schnoll-Sussman|2018-03-09